<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
  <title>PRZOOM - Newswire - Free Press Release Distribution - Research</title>
  <link>http://www.przoom.com/</link>
  <description>Recent Research - PRZOOM Press Releases - NewswireToday Headline News - Visit  PRNewswireDistribution.com</description>
  <pubDate>Wed, 07 Jan 2009 07:05:22 -0500</pubDate>
  <category>Research</category>
 <generator>rss20 by http://www.przoom.com/</generator>
 <webMaster>newsfeed_888@przoom.com</webMaster>

<item>
  <photo>images/nophoto.gif</photo>
  <title>ITRI - Taiwan Focuses on C Liver Medic’s R&amp;D to Reach USD 6 Billion Potential Market in the World</title>
  <description>PRZOOM - Newswire (press release) - 12/24/2008, Taipei,  Taiwan - To reach 6 billion potential market, The Industrial Technology Research Institute (ITRI) held the 2008 International Symposium on Chronic Hepatitis &amp; Liver Diseases for not only treatment development but prevention on the topic in Taipei, Taiwan</description>
  <link>http://www.przoom.com/news/44391/</link>
  <pubDate>12/24/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>GenScript Launches A Series of Beta Amyloid Peptides Geared Toward Alzheimer's Disease Research</title>
  <description>PRZOOM - Newswire (press release) - 12/12/2008, Piscataway, NJ United States - International contract research organization (CRO) GenScript Corporation has launched a series of beta amyloid peptide fragments targeting Alzheimer's disease (AD)</description>
  <link>http://www.przoom.com/news/43982/</link>
  <pubDate>12/12/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>BioInformant Announces Key Enhancements to its Targeted Email Lists</title>
  <description>PRZOOM - Newswire (press release) - 11/02/2008, Arlington, VA United States - Since its inception, BioInformant has offered targeted email lists based on area of research area, such as gene therapy, angiogenesis, immunology, or RNAi. Now, BioInformant is also offering targeted email lists broken down geographic location</description>
  <link>http://www.przoom.com/news/42029/</link>
  <pubDate>11/02/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Trevigen Launches Pharmacodynamic PAR ELISA Assay</title>
  <description>PRZOOM - Newswire (press release) - 10/08/2008, Arlington, VA United States - Trevigen introduces a highly sensitive, quantitative and validated assay to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening</description>
  <link>http://www.przoom.com/news/40915/</link>
  <pubDate>10/08/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>ISIS Services Welcomes Alex LaBeaux as Director of Sales and Marketing</title>
  <description>PRZOOM - Newswire (press release) - 10/07/2008, Berkeley, CA United States - ISIS Services appoints Alex LaBeaux as their Director of Sales and Marketing</description>
  <link>http://www.przoom.com/news/40847/</link>
  <pubDate>10/07/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>CERN Reports Incident in Large Hadron Collider Sector 34</title>
  <description>PRZOOM - Newswire (press release) - 09/21/2008, Geneva,  Switzerland - European Organization for Nuclear Research - During commissioning of the final LHC sector at high current for operation at 5 TeV, an incident occurred at mid-day on Friday 19 September resulting in a large helium leak into the tunnel</description>
  <link>http://www.przoom.com/news/40091/</link>
  <pubDate>09/21/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>New Research Highlights that Manufacturers Lack Day-to-Day Visibility of Channel Activities</title>
  <description>PRZOOM - Newswire (press release) - 09/09/2008, Gatineau, Québec Canada - More than 50% of VARs surveyed expect managed services to grow by up to 30% over next 24 months. Issues around discounts, pricing, training, marketing and sales appear to continuously arise between manufacturers and VARs according to study</description>
  <link>http://www.przoom.com/news/39508/</link>
  <pubDate>09/09/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Innovative Ohio Biotech Company Awarded Contract with U.S Army to Study PTSD and TBI</title>
  <description>PRZOOM - Newswire (press release) - 09/02/2008, Albany, OH United States - Sound Health - Innovative study projected to produce a quantitative, mobile, non-invasive identification of close proximity acoustic blast injuries and, ultimately, the restitution of normal brain function and emotional stability for returning soldiers</description>
  <link>http://www.przoom.com/news/39161/</link>
  <pubDate>09/02/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>France’s ITER Cadarache Issues Call To Tender</title>
  <description>PRZOOM - Newswire (press release) - 08/29/2008, London,  United Kingdom - France has been chosen to host the ITER research centre at Cadarache, in the south of France. The project will involve the construction of an experimental nuclear-fusion reactor using hydrogen isotopes</description>
  <link>http://www.przoom.com/news/39037/</link>
  <pubDate>08/29/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Electronics.ca Publications Releases New Study - '3D TSV Interconnects: Equipments and Materials Report'</title>
  <description>PRZOOM - Newswire (press release) - 07/29/2008, Montréal, Québec Canada - The latest market forecasts show that 3D-TSV wafers will be shipped in millions and have the potential to impact as much as 25% of the memory business by 2015. If we exclude memories, our analysis show that 3D-TSV wafers will account for more than 6%</description>
  <link>http://www.przoom.com/news/37652/</link>
  <pubDate>07/29/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Thermo Fisher Scientific Publishes Poster on the Capability of Collision Cell-based ICP-MS</title>
  <description>PRZOOM - Newswire (press release) - 07/21/2008, Holmes Chapel, Cheshire United Kingdom - Thermo Fisher Scientific publishes poster on the capability of collision cell-based ICP-MS to analyze multi-elemental environmental and geological samples (NYSE: TMO)</description>
  <link>http://www.przoom.com/news/37318/</link>
  <pubDate>07/21/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>ISIS Services to Host Interactive Live Videocast at 3rd International Conference on NOTES™</title>
  <description>PRZOOM - Newswire (press release) - 07/08/2008, Berkeley, CA United States - ISIS Services will serve as the host site for a series of procedures that will be videocast to the Palace Hotel at the NOTES Conference. The release discusses the history of NOTES procedures, as well as ISIS' video conferencing capabilities</description>
  <link>http://www.przoom.com/news/36741/</link>
  <pubDate>07/08/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>40-30 Helps CERN Build World’s Most Powerful Particle Accelerator</title>
  <description>PRZOOM - Newswire (press release) - 07/04/2008, London,  United Kingdom - French company 40-30, a specialist in maintenance systems, is working with CERN (European Organisation for Nuclear Research) on the construction of the world’s largest and most powerful particle accelerator</description>
  <link>http://www.przoom.com/news/36604/</link>
  <pubDate>07/04/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Trevigen Announces A Highly Sensitive Fluorescent One Hour PARP Inhibition Assay</title>
  <description>PRZOOM - Newswire (press release) - 06/20/2008, Arlington, VA United States - Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these drawbacks with the release of the HT Fluorescent Homogeneous PARP Inhibition Assay</description>
  <link>http://www.przoom.com/news/35987/</link>
  <pubDate>06/20/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Apoptosis Offers New Dimension to Cancer Therapeutics and Prospects for Commercial Benefits</title>
  <description>PRZOOM - Newswire (press release) - 06/10/2008, Palo Alto, CA United States - Extensive cancer research reveals more than 90 percent of cancers occur due to genetic mutations</description>
  <link>http://www.przoom.com/news/35407/</link>
  <pubDate>06/10/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>France’s Excellence in Clinical Trials Attracts Top Companies</title>
  <description>PRZOOM - Newswire (press release) - 06/05/2008, London,  United Kingdom - Companies look to France as the centre of excellence for medical and pharmaceutical research, since the effective and well-regulated management of clinical trials in specialist hospitals represents a vital stage in developing new treatments</description>
  <link>http://www.przoom.com/news/35237/</link>
  <pubDate>06/05/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Trevigen Releases the First Standardized 3-D Culture Cell Harvesting Kit</title>
  <description>PRZOOM - Newswire (press release) - 05/22/2008, Arlington, VA United States - Trevigen releases the first standardized kit for isolating cells from 3-D Culture for biochemical analysis. The Cultrex® 3-D Culture Cell Haversting Kit is based on a nonenzymatic approach which prevents biochemical degradation during processing</description>
  <link>http://www.przoom.com/news/34595/</link>
  <pubDate>05/22/2008</pubDate>
  <category>Research</category>
</item>

<item>
  <photo>images/nophoto.gif</photo>
  <title>Life Sciences Research Moving Towards Excellence in Europe</title>
  <description>PRZOOM - Newswire (press release) - 05/15/2008, London,  United Kingdom - Life sciences funding is witnessing unprecedented increases in recent years, pressuring the EU to keep pace with the United States. The cohesion of research policies and funding channels across Europe will be necessary to achieve this objective</description>
  <link>http://www.przoom.com/news/34220/</link>
  <pubDate>05/15/2008</pubDate>
  <category>Research</category>
</item>

</channel>
</rss>